Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

October 8, 2023

ACTRIMS 2023: Documentary offers hope for the Black MS community

  • Health Equity
    /
  • Healthcare Perspectives
    /
  • Multiple Sclerosis
    /
 MS expert, advocate discuss need for greater visibility and awareness by Lindsey Shapiro, PhD | March 2, 2023 Multiple sclerosis (MS) has long been…
Health Equity

October 5, 2023

Signs That You’re Transitioning to Another Stage of MS

  • Additional MS resource sites
    /
  • MS Research Study and Reports
    /
  Signs That You’re Transitioning to Another Stage of MS   Research show that Blacks develop Multiple Sclerosis more often…
Additional MS resource sites

October 3, 2023

The topographical model of #MS – comments from the creator, Stephen Krieger, MD

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
The topographical model of #MS = By Stephen Krieger, MD — The topographical model of #MS is my career contribution,…
MS Research Study and Reports

October 3, 2023

ECTRIMS: Sanofi to Present New Data for Tolebrutinib and Growing MS Pipeline

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
Media Update: Sanofi presents new data from robust MS clinical pipeline exploring multiple approaches to address important unmet patient needs…
MS Drug Therapies

October 2, 2023

Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD

  • MS Drug Therapies
    /
  • NMO (NMOSD/Devics)
    /
 Late-breaking results from Phase III trial of Ocrevus (ocrelizumab) subcutaneous injection and Phase II trial of BTK inhibitor fenebrutinib in…
MS Drug Therapies

October 2, 2023

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

  • NMO (NMOSD/Devics)
    /
  Abstract Objective:  To evaluate clinical features among patients with neuromyelitis optica spectrum disorders (NMOSD) who have myelin oligodendrocyte glycoprotein…
NMO (NMOSD/Devics)

October 1, 2023

DEMENTIA – an overview, causes and symptoms

  • Neurologic Illnesses
    /
  • Syndromes & etc
    /
Overview Dementia is a term used to describe a group of symptoms affecting memory, thinking and social abilities. In people…
Neurologic Illnesses

September 29, 2023

Reframing MS — A new Patient resource with Jamie-Lynn Sigler (Sopranos)

  • Additional MS resource sites
    /
  • An MS Patients Story
    /
 Novartis is collaborating with mom, actor, MS advocate, and KESIMPTA patient Jamie-Lynn Sigler to share what she has learned in…
Additional MS resource sites

September 28, 2023

Barriers in MS Treatment Adherence

  • Additional MS resource sites
    /
  • MS BIOMARKERS
    /
  2023 , Octave Although there currently is no cure for multiple sclerosis, in recent decades, 20+ disease-modifying therapies (DMTs)…
Additional MS resource sites

September 22, 2023

Generic and Biosimilar Medications for MS

  • MS Drug Therapies
    /
  • MS Specialty Pharmacy
    /
  • National MS Society Related
    /
 Generics and biosimilars are follow-on medications. A generic is a follow-on medication to a brand medication and a biosimilar is…
MS Drug Therapies

Categories

Latest Blog Posts